These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 19151962)

  • 21. Factors influencing cardiometabolic risk profile in patients with psoriasis.
    Curcó N; Barriendos N; Barahona MJ; Arteaga C; García M; Yordanov S; De La Barrera O; Prat C; Vives P; Giménez N
    Australas J Dermatol; 2018 May; 59(2):e93-e98. PubMed ID: 28240341
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiovascular risk factors in high-need psoriasis patients and its implications for biological therapies.
    Driessen RJ; Boezeman JB; Van De Kerkhof PC; De Jong EM
    J Dermatolog Treat; 2009; 20(1):42-7. PubMed ID: 18649164
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiovascular and other comorbidities in patients with psoriatic arthritis: a comparison with patients with psoriasis.
    Husted JA; Thavaneswaran A; Chandran V; Eder L; Rosen CF; Cook RJ; Gladman DD
    Arthritis Care Res (Hoboken); 2011 Dec; 63(12):1729-35. PubMed ID: 21905258
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiovascular comorbidities in psoriasis and psoriatic arthritis: pathogenesis, consequences for patient management, and future research agenda: a report from the GRAPPA 2009 annual meeting.
    Boehncke WH; Gladman DD; Chandran V
    J Rheumatol; 2011 Mar; 38(3):567-71. PubMed ID: 21362790
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recommendations for detection of individual risk for comorbidities in patients with psoriasis.
    Wohlrab J; Fiedler G; Gerdes S; Nast A; Philipp S; Radtke MA; Thaçi D; Koenig W; Pfeiffer AF; Härter M; Schön MP
    Arch Dermatol Res; 2013 Mar; 305(2):91-8. PubMed ID: 23377136
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic syndrome and psoriatic arthritis among patients with psoriasis vulgaris: Quality of life and prevalence.
    Souza CS; de Castro CCS; Carneiro FRO; Pinto JMN; Fabricio LHZ; Azulay-Abulafia L; Romiti R; Cestari TF; Suzuki CE; Biegun PM; Guedes LS; Oyafuso LKM
    J Dermatol; 2019 Jan; 46(1):3-10. PubMed ID: 30474868
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Research gaps in psoriasis: opportunities for future studies.
    Ryan C; Korman NJ; Gelfand JM; Lim HW; Elmets CA; Feldman SR; Gottlieb AB; Koo JY; Lebwohl M; Leonardi CL; Van Voorhees AS; Bhushan R; Menter A
    J Am Acad Dermatol; 2014 Jan; 70(1):146-67. PubMed ID: 24126079
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities.
    Elmets CA; Leonardi CL; Davis DMR; Gelfand JM; Lichten J; Mehta NN; Armstrong AW; Connor C; Cordoro KM; Elewski BE; Gordon KB; Gottlieb AB; Kaplan DH; Kavanaugh A; Kivelevitch D; Kiselica M; Korman NJ; Kroshinsky D; Lebwohl M; Lim HW; Paller AS; Parra SL; Pathy AL; Prater EF; Rupani R; Siegel M; Stoff B; Strober BE; Wong EB; Wu JJ; Hariharan V; Menter A
    J Am Acad Dermatol; 2019 Apr; 80(4):1073-1113. PubMed ID: 30772097
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Psoriasis: comorbidities and associations.
    Farley E; Menter A
    G Ital Dermatol Venereol; 2011 Feb; 146(1):9-15. PubMed ID: 21317853
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psoriasis and comorbid diseases: Epidemiology.
    Takeshita J; Grewal S; Langan SM; Mehta NN; Ogdie A; Van Voorhees AS; Gelfand JM
    J Am Acad Dermatol; 2017 Mar; 76(3):377-390. PubMed ID: 28212759
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Psoriasis and cardiovascular disease: the elusive link.
    Manolis AA; Manolis TA; Melita H; Manolis AS
    Int Rev Immunol; 2019; 38(1):33-54. PubMed ID: 30457023
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Psoriasis is a systemic disease with multiple cardiovascular and metabolic comorbidities.
    Ryan C; Kirby B
    Dermatol Clin; 2015 Jan; 33(1):41-55. PubMed ID: 25412782
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Psoriasis and cardiovascular disorders.
    Ryan C; Menter A
    G Ital Dermatol Venereol; 2012 Apr; 147(2):179-87. PubMed ID: 22481581
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exploring the association between cardiovascular and other disease-related risk factors in the psoriasis population: the need for increased understanding across the medical community.
    Menter A; Griffiths CE; Tebbey PW; Horn EJ; Sterry W;
    J Eur Acad Dermatol Venereol; 2010 Dec; 24(12):1371-7. PubMed ID: 20384692
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiovascular health for patients with psoriasis: a précis for front-line clinicians.
    Federman DG; Shelling ML; Prodanovich S; Gunderson CG; Kirsner RS
    Ostomy Wound Manage; 2009 May; 55(5):38-47. PubMed ID: 19471047
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Position statement for the management of comorbidities in psoriasis.
    Dauden E; Blasco AJ; Bonanad C; Botella R; Carrascosa JM; González-Parra E; Jodar E; Joven B; Lázaro P; Olveira A; Quintero J; Rivera R
    J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2058-2073. PubMed ID: 29992631
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions.
    Davidovici BB; Sattar N; Prinz J; Puig L; Emery P; Barker JN; van de Kerkhof P; Ståhle M; Nestle FO; Girolomoni G; Krueger JG
    J Invest Dermatol; 2010 Jul; 130(7):1785-96. PubMed ID: 20445552
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psoriasis in Patients with Metabolic Syndrome or Type 2 Diabetes Mellitus: Treatment Challenges.
    Pannu S; Rosmarin D
    Am J Clin Dermatol; 2021 May; 22(3):293-300. PubMed ID: 33586126
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of the community nurse in psoriatic comorbidities interventions.
    Aldridge A
    Br J Community Nurs; 2014 Jan; 19(1):38-42. PubMed ID: 24800325
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Psoriasis, metabolic syndrome and cardiovascular risk factors. A population-based study.
    Fernández-Armenteros JM; Gómez-Arbonés X; Buti-Soler M; Betriu-Bars A; Sanmartin-Novell V; Ortega-Bravo M; Martínez-Alonso M; Garí E; Portero-Otín M; Santamaria-Babi L; Casanova-Seuma JM
    J Eur Acad Dermatol Venereol; 2019 Jan; 33(1):128-135. PubMed ID: 29953676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.